Key findings
- 2445 people across Australia participated in the TraX study during the reporting period. Most participants were from New South Wales (83.1%).
- At study entry, 24.7% of participants reported being unvaccinated against MPOX, 47.2% had received one MPOX vaccination, and 28.1% had received two MPOX vaccinations.
- At study entry, nine participants reported a prior incidence of MPOX infection.
- No new cases of MPOX were reported during the study period, precluding any calculations on vaccine effectiveness.